Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: A mixed treatment comparison

P. Baji, M. Péntek, L. Czirják, Z. Szekanecz, G. Nagy, L. Gulácsi, V. Brodszky

Research output: Contribution to journal › Article (Academic Journal) › peer-review

32 Citations (Scopus)

Original language	English
Journal	European Journal of Health Economics
DOIs	https://doi.org/10.1007/s10198-014-0594-4
Publication status	Published - 2014

Access to Document

@article{1e3168c70d6145d38771333449c9e451,

title = "Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: A mixed treatment comparison",

author = "P. Baji and M. P{\'e}ntek and L. Czirj{\'a}k and Z. Szekanecz and G. Nagy and L. Gul{\'a}csi and V. Brodszky",

year = "2014",

doi = "10.1007/s10198-014-0594-4",

language = "English",

journal = "European Journal of Health Economics",

issn = "1618-7598",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: A mixed treatment comparison

AU - Baji, P.

AU - Péntek, M.

AU - Czirják, L.

AU - Szekanecz, Z.

AU - Nagy, G.

AU - Gulácsi, L.

AU - Brodszky, V.

PY - 2014

Y1 - 2014

UR - https://www.scopus.com/pages/publications/84905684573

U2 - 10.1007/s10198-014-0594-4

DO - 10.1007/s10198-014-0594-4

M3 - Article (Academic Journal)

SN - 1618-7598

JO - European Journal of Health Economics

JF - European Journal of Health Economics

ER -